World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
93
Citations
33375
World Ranking
963
National Ranking
530

Medicine

D-Index
94
Citations
33782
World Ranking
10458
National Ranking
5382

Henry H. Balfour publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Henry H. Balfour sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 352 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Henry H. Balfour D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Henry H. Balfour sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Henry H. Balfour is affiliated with the University of Minnesota in the United States with a research focus concentrated primarily in the field of Medicine. Their scholarly work spans multiple specialized subfields including Oncology, Epidemiology, Immunology, Infectious Diseases, and Pathology and Forensic Medicine.

The scientist's primary research topics include:

  • Viral-associated cancers and disorders
  • Cytomegalovirus and herpesvirus research
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Polyomavirus and related diseases
  • Parvovirus B19 Infection Studies

Henry H. Balfour has authored several notable papers, among them:

  • "Epstein-Barr virus infection status among first year undergraduate university students" (2020, Journal of American College Health)
  • "Immortalization and functional screening of natively paired human T cell receptor repertoires" (2021, Protein Engineering Design and Selection)
  • "Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine" (2022, Vaccines)
  • "Atovaquone Compared with Dapsone for the Prevention of Pneumocystis carinii Pneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both" (2021, Columbia Academic Commons - Columbia University)
  • "A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less" (2020, UNC Libraries)

The venues in which Henry H. Balfour publishes frequently include:

  • Journal of Clinical Virology
  • SSRN Electronic Journal
  • Protein Engineering Design and Selection
  • Scientific Reports
  • Journal of American College Health

Collaboration is a significant aspect of Henry H. Balfour's scientific activity. Frequent co-authors are:

  • Jennifer M. Geris
  • Ahmed S. Fahad
  • Sheila N. López Acevedo
  • Nicoleen Boyle
  • Bharat Madan

Best Publications

  • A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

    Scott M. Hammer;Kathleen E. Squires;Michael D. Hughes;Michael D. Hughes;Janet M. Grimes

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

    Robert J. Risdall;Robert W. McKenna;Mark E. Nesbit;William Krivit

  • Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue

    Ashley T. Haase;Keith Henry;Mary Zupancic;Gerlad Sedgewick

  • Survival of Influenza Viruses on Environmental Surfaces

    B. Bean;B. M. Moore;B. Sterner;L. R. Peterson

  • A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts

    Henry H. Balfour;Beverly A. Chace;Jack T. Stapleton;Richard L. Simmons

  • Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

    D. W. Hanto;G. Frizzera;K. J. Gajl-Peczalska;K. Sakamoto

  • Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

    Oludare A. Odumade;Kristin A. Hogquist;Henry H. Balfour

  • Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

    Douglas W. Hanto;Kazimiera J. Gajl-peczalska;Glauco Frizzera;Diane C. Arthur

  • Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients

    Alejo Erice;Sunwen Chou;Karen K. Biron;Sylvia C. Stanat;Sylvia C. Stanat

  • Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation

    Joel D. Meyers;Joel D. Meyers;Joel D. Meyers;Elizabeth C. Reed;David H. Shepp;David H. Shepp;David H. Shepp;Mark Thornquist;Mark Thornquist;Mark Thornquist

  • Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.

    Phillip K. Peterson;Henry H. Balfour;Stephen C. Marker;David S. Fryd

  • Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

    Balfour Hh;Bean B;Laskin Ol;Ambinder Rf

  • Primary Epstein-Barr virus infection

    Samantha K. Dunmire;Priya S. Verghese;Henry H. Balfour

  • Failure of automatic control of ventilation (Ondine's curse). Report of an infant born with this syndrome and review of the literature.

    Robert B. Mellins;Henry H. Balfour;Gerard M. Turino;Robert W. Winters

  • Herpes Simplex Virus Resistant to Acyclovir: A Study in a Tertiary Care Center

    Janet A. Englund;Mark E. Zimmerman;Ella M. Swierkosz;Jesse L. Goodman

  • Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students

    Henry H. Balfour;Oludare A. Odumade;David O. Schmeling;Beth D. Mullan

  • Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.

    Wesley Miller;Patrick Flynn;Jeffrey McCullough;Henry H. Balfour

  • A Controlled Trial of Acyclovir for Chickenpox in Normal Children

    Lisa M. Dunkle;Ann M. Arvin;Richard J. Whitley;Harley A. Rotbart

  • Respiratory syncytial virus infection in immunocompromised adults.

    J. A. Englund;C. J. Sullivan;M. C. Jordan;L. P. Dehner

  • Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

    Alejo Erice;Douglas L. Mayers;David G. Strike;Kim J. Sannerud

  • Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host

    Joel D. Meyers;James C. Wade;Charles D. Mitchell;Rein Saral

  • Therapy of herpes zoster with oral acyclovir

    J. C. Huff;B. Bean;H. H. Balfour;O. L. Laskin

  • Parainfluenza virus respiratory infection after bone marrow transplantation.

    Wendt Ch;Weisdorf Dj;Jordan Mc;Balfour Hh

  • Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition

    Henry H. Balfour;Frangiscos Sifakis;Joseph A. Sliman;Jennifer A. Knight

Frequent Co-Authors

Janet A. Englund
Janet A. Englund Seattle Children's Hospital
John S. Najarian
John S. Najarian University of Minnesota
Kristin A. Hogquist
Kristin A. Hogquist University of Minnesota
Phillip K. Peterson
Phillip K. Peterson University of Minnesota
Margaret A. Fischl
Margaret A. Fischl University of Miami
Paul A. Volberding
Paul A. Volberding University of California, San Francisco
J. Brooks Jackson
J. Brooks Jackson University of Iowa Hospitals and Clinics
Chun C. Chao
Chun C. Chao University of Minnesota
Richard L. Simmons
Richard L. Simmons University of Pittsburgh
Arthur J. Matas
Arthur J. Matas University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their Immunology knowledge, exploring related healthcare degrees online is a strategic step. Many professionals consider specializing further by choosing programs like the best online psychiatric mental health nurse practitioner programs, which offer strong clinical placements essential for hands-on experience.

Cost is a significant consideration, and prospective students often seek the cheapest psychiatric nurse practitioner programs to reduce financial burden while gaining quality education. These affordable options make specialized training more accessible.

Career advancement and compensation are closely linked. Those pursuing a Doctor of Nursing Practice (DNP) degree can find useful insights on highest paid dnp specialties, helping tailor their education towards financially rewarding fields.

Transitioning between specializations is common. For example, nurses moving from family practice to more acute roles might explore acnp programs, which provide targeted training for acute care nurse practitioner roles.

These pathways highlight how interdisciplinary study and specialized training can enhance a career in Immunology-related healthcare, combining online education with practical career growth.

Best Scientists Citing Henry H. Balfour

Trending Scientists

Recently Published Articles